Article Details
Retrieved on: 2021-04-21 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Patients with multiple sclerosis (MS) taking the monoclonal antibody ocrelizumab were shown to produce less of an immune response to infection with ...
Article found on: www.ajmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here